Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

The Novel Proteasome Inhibitor CEP-18770 Inhibits Myeloma Tumor Growth In Vitro and In Vivo and Enhances the Anti-MM Effects of Melphalan

Eric SancheZ, Richard A Campbell, BS, Jeffrey A Steinberg, Mingjie Li, Haiming Chen, MD, PhD, Benjamin Bonavida, PhD, James R. Berenson, MD

Blood (2008) 112 (11): 843.

https://doi.org/10.1182/blood.V112.11.843.843

Published: 2008

Journal Articles

The Novel Potent Pan-Deacetylase (DAC) Inhibitor, Panobinostat (LBH589), Markedly Enhances the Anti-Myeloma Effects of Chemotherapy In Vitro and In Vivo .

Richard A. Campbell, BS, Eric Sanchez, BA, Jeffrey Steinberg, BS, Michael Share, BA, Joseph Wang, Mingjie Li, Haiming Chen, MD, PhD, Dror Shalitin, PhD, Shen Pang, PhD, Jonathan Said, MD, James R. Berenson, MD

Blood (2007) 110 (11): 2520.

https://doi.org/10.1182/blood.V110.11.2520.2520

Published: 2007

Journal Articles

The Combination of the mTOR Inhibitor Rapamycin and Protein Kinase C Inhibitors Produces Marked Synergistic Anti-Myeloma Effects.

Dror Shalitin, PhD, Michael Share, BA, Richard A. Campbell, BS, Jeffrey Steinberg, BS, Eric Sanchez, BA, Joseph Wang, Richard Leuchter, Mingjie Li, Cathy S. Wang, BS, Haiming Chen, MD, PhD, James R. Berenson, MD

Blood (2007) 110 (11): 4800.

https://doi.org/10.1182/blood.V110.11.4800.4800

Published: 2007

Journal Articles

The mTOR Inhibitor RAD001 (Everolimus) Inhibits Myeloma Tumor Growth In Vivo and Enhances the Anti-MM Effects of Bortezomib and Arsenic Trioxide.

Richard A. Campbell, BS, Eric Sanchez, BA, Jeffrey Steinberg, BS, Michael Share, BA, Joseph Wang, Mingjie Li, Richard Leuchter, Haiming Chen, MD, PhD, Dror Shalitin, PhD, Shen Pang, PhD, Jonathan Said, MD, James R. Berenson, MD

Blood (2007) 110 (11): 4801.

https://doi.org/10.1182/blood.V110.11.4801.4801

Published: 2007

Journal Articles

An Anti-VEGF Antibody, in Combination with Bortezomib, Markedly Inhibits Tumor Growth in SCID-hu Models of Human Multiple Myeloma.

Blood (2007) 110 (11): 4802.

https://doi.org/10.1182/blood.V110.11.4802.4802

Published: 2007

Journal Articles

Identification of Novel Receptors on Myeloma Cells and Monocytes That Contribute to Myeloma Tumor Proliferation and Angiogenesis.

Melinda S. Gordon, PhD, Hee Jin Lee, BS, Richard A. Campbell, BS, Haiming Chen, MD, Ph.D, Benjamin Bonavida, PhD, James R. Berenson, MD

Blood (2005) 106 (11): 2507.

https://doi.org/10.1182/blood.V106.11.2507.2507

Published: 2005

Journal Articles

Peripheral Blood Cells from Multiple Myeloma Patients Show Increased Osteoclast and Decreased Osteoblast Gene Expression.

Melinda S. Gordon, PhD, Ariana M. Berenson, Charles B. Drucker, Matthew Katz, Hee Jin Lee, BS, Richard A. Campbell, BS, Haiming Chen, MD, PhD, Howard S. Yeh, MD, Benjamin Bonavida, PhD, Jonathan Said, MD, James R. Berenson, MD

Blood (2005) 106 (11): 5098.

https://doi.org/10.1182/blood.V106.11.5098.5098

Published: 2005

Journal Articles

Arsenic Trioxide Shows Synergistic Anti-Myeloma Effects When Combined with Bortezomib and Melphalan In Vitro and Helps Overcome Resistance of Multiple Myeloma Cells to These Treatments in Vivo.

Richard A. Campbell, BS, Haiming Chen, MD, PhD, Daocheng Zhu, MD, PhD, Janice C. Santos, BS, MS, Benjamin Bonavida, PhD, Shen Pang, PhD, Jonathan Said, MD, James R. Berenson, MD

Blood (2004) 104 (11): 2467.

https://doi.org/10.1182/blood.V104.11.2467.2467

Published: 2004

Journal Articles

Ascorbic Acid Overcomes Drug Resistance in Myeloma and Significantly Increases the Anti-Myeloma Effects of both Arsenic Trioxide and Melphalan in Vitro and in Vivo.

Richard A. Campbell, BS, Haiming Chen, MD, PhD, Daocheng Zhu, MD, PhD, Janice C. Santos, BS, MS, Benjamin Bonavida, PhD, Shen Pang, PhD, Jonathan Said, MD, James R. Berenson, MD

Blood (2004) 104 (11): 2470.

https://doi.org/10.1182/blood.V104.11.2470.2470

Published: 2004

Journal Articles

Inhibition of Multiple Myeloma Cell Proliferation and Increase of Apoptosis through Regulation of the NF-κB and JNK Pathways by Silencing TRAF6 C-Domain mRNA.

Haiming Chen, MD, PhD, Richard A. Campbell, BS, Daocheng Zhu, MD, PhD, Sonia Guangxu Li, BS, Christine Pan James, BA, Janice Santos, BS, MS, Cathy S. Wang, BS, Benjamin Bonavida, PhD, James R. Berenson, MD

Blood (2004) 104 (11): 3355.

https://doi.org/10.1182/blood.V104.11.3355.3355

Published: 2004

Journal Articles

Pleitrophin Is Highly Expressed by Myeloma Cells, Elevated in the Serum of Myeloma Patients, and Is a New Autocrine Growth Factor for This B Cell Malignancy.

Haiming Chen, MD, PhD, Daocheng Zhu, MD, PhD, Richard A. Campbell, BS, Christine Pan James, BA, Sonia Guangxu Li, BS, Janice Santos, BS, MS, Cathy S. Wang, BS, Benjamin Bonavida, PhD, James R. Berenson, MD

Blood (2004) 104 (11): 3349.

https://doi.org/10.1182/blood.V104.11.3349.3349

Published: 2004

Journal Articles

Pleitrophin Alone Induces Transdifferentiation of Human Monocytes and Bone Marrow Stem Cells into Endothelial Cells.

Haiming Chen, MD, PhD, Daocheng Zhu, MD, PhD, Richard A. Campbell, BS, Christine Pan James, BA, Cathy S. Wang, BS, Janice Santos, BS, MS, Benjamin Bonavida, Phd, James R. Berenson, MD

Blood (2004) 104 (11): 1472.

https://doi.org/10.1182/blood.V104.11.1472.1472

Published: 2004

NARROW

The Novel Proteasome Inhibitor CEP-18770 Inhibits Myeloma Tumor Growth In Vitro and In Vivo and Enhances the Anti-MM Effects of Melphalan

The Novel Potent Pan-Deacetylase (DAC) Inhibitor, Panobinostat (LBH589), Markedly Enhances the Anti-Myeloma Effects of Chemotherapy In Vitro and In Vivo .

The Combination of the mTOR Inhibitor Rapamycin and Protein Kinase C Inhibitors Produces Marked Synergistic Anti-Myeloma Effects.

The mTOR Inhibitor RAD001 (Everolimus) Inhibits Myeloma Tumor Growth In Vivo and Enhances the Anti-MM Effects of Bortezomib and Arsenic Trioxide.

An Anti-VEGF Antibody, in Combination with Bortezomib, Markedly Inhibits Tumor Growth in SCID-hu Models of Human Multiple Myeloma.

Identification of Novel Receptors on Myeloma Cells and Monocytes That Contribute to Myeloma Tumor Proliferation and Angiogenesis.

Peripheral Blood Cells from Multiple Myeloma Patients Show Increased Osteoclast and Decreased Osteoblast Gene Expression.

Arsenic Trioxide Shows Synergistic Anti-Myeloma Effects When Combined with Bortezomib and Melphalan In Vitro and Helps Overcome Resistance of Multiple Myeloma Cells to These Treatments in Vivo.

Ascorbic Acid Overcomes Drug Resistance in Myeloma and Significantly Increases the Anti-Myeloma Effects of both Arsenic Trioxide and Melphalan in Vitro and in Vivo.

Inhibition of Multiple Myeloma Cell Proliferation and Increase of Apoptosis through Regulation of the NF-κB and JNK Pathways by Silencing TRAF6 C-Domain mRNA.

Pleitrophin Is Highly Expressed by Myeloma Cells, Elevated in the Serum of Myeloma Patients, and Is a New Autocrine Growth Factor for This B Cell Malignancy.

Pleitrophin Alone Induces Transdifferentiation of Human Monocytes and Bone Marrow Stem Cells into Endothelial Cells.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only